Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison
Patients with non-metastatic unresectable hepatocellular carcinoma
Non-metastatic Hepatocellular Carcinoma
OTHER: TACE + hypofractionated EBRT|PROCEDURE: Surgical resection
Disease-free survival of the patient after start of treatment, Disease-Free Survival (DFS) defined as the time (in months) between the treatment (surgical resection or TACE) and the diagnostic of local, locoregional or distant recurrence, or date of death from any cause; patients who are alive or lost to follow-up at the time of the analysis will be censored on the last follow-up date; patients who have received a liver transplant for non-carcinologic reason will be censored on the date of transplantation., Within 10 years after the treatment (surgical resection or TACE)
Patients with non-metastatic unresectable hepatocellular carcinoma